Home / Expertise / Life Sciences & Healthcare
Lab

Life Sciences & Healthcare

United Arab Emirates

Dubai’s vision to become a hub for healthcare tourism, the rapid expansion of local and expat populations across the Middle East, as well as the region’s unique demographics, give rise to opportunities and challenges for investors in the lifesciences and healthcare sectors.

We work with and have established long-term relationships with the top 100 lifesciences companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.  We also support clinics, hospitals, and other service providers active in the healthcare sector, and private investors in such businesses, across the Middle East. Our experts advise leading global business groups in the sector on transactions, commercial agreements, compliance, investigations and litigation, very often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

With over 150 international specialist lawyers across CMS, we understand the scientific and commercial as well as the legal imperatives affecting your lifesciences and healthcare businesses. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice.

Read more Read less
High­lights of our ex­per­i­ence in Lifes­ci­ences in UAE

Feed

Show only
Dec 2018
CMS Life Sci­ences & Health­care Sec­tor Group: An over­view...
03 Jul 19
UAE up­date: re­lax­a­tion of for­eign own­er­ship re­stric­tions
In 2018 the UAE passed the For­eign Dir­ect In­vest­ment Law (the “FDI Law’), which was in­ten­ded to pave the way to re­lax­ing for­eign own­er­ship re­stric­tions on com­pan­ies re­gistered “on­shore” in the...
1 May 2017
CMS, Nabarro and Olswang com­plete ground­break­ing mer­ger...
Strength­en­ing CM­S' po­s­i­tion across Middle East and...
24 Aug 18
Gov­ern­ment Is­sues Brexit Tech­nic­al No­tice for Life Sci­ences
On 23 Au­gust 2018, the UK Gov­ern­ment (the "Gov­ern­ment") is­sued the first wave of its tech­nic­al pa­pers de­signed to provide guid­ance to com­pan­ies to help pre­pare for a "No Deal" Brexit. In this scen­ario,...
07/03/2016
CMS builds Is­lam­ic Fin­ance Prac­tice with new part­ner...